Clinical Trials Browser

Recurrent Malignant Solid Neoplasm × sapanisertib × Other solid neoplasm × Clear all

NCT03430882 2022-06-21

Sapanisertib, Carboplatin, and Paclitaxel in Treating Patients With Recurrent or Refractory Malignant Solid Tumors

Phase 1 Completed

Other solid neoplasm

Recurrent Malignant Solid Neoplasm